These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24787438)

  • 1. Europe as leaders in nanomedicine: let's go for it!
    Lévy L
    Nanomedicine (Lond); 2014 Apr; 9(4):389-91. PubMed ID: 24787438
    [No Abstract]   [Full Text] [Related]  

  • 2. Nanotechnology and glaucoma: a review of the potential implications of glaucoma nanomedicine.
    Kim NJ; Harris A; Gerber A; Tobe LA; Amireskandari A; Huck A; Siesky B
    Br J Ophthalmol; 2014 Apr; 98(4):427-31. PubMed ID: 24246373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kindling translational cancer nanotechnology research.
    Chapman S; Panaro NJ; Hinkal GW; Hook SS; Prabhakar U; Ptak K; Farrell D; Grodzinski P
    Nanomedicine (Lond); 2012 Mar; 7(3):321-5. PubMed ID: 22385196
    [No Abstract]   [Full Text] [Related]  

  • 4. Theranostic nanomedicine with functional nanoarchitecture.
    Pan D
    Mol Pharm; 2013 Mar; 10(3):781-2. PubMed ID: 23452025
    [No Abstract]   [Full Text] [Related]  

  • 5. The photonic nanomedicine revolution: let the human side of nanotechnology emerge.
    Halas NJ
    Nanomedicine (Lond); 2009 Jun; 4(4):369-71. PubMed ID: 19505237
    [No Abstract]   [Full Text] [Related]  

  • 6. Multifunctional radionanomedicine: a novel nanoplatform for cancer imaging and therapy.
    Muthu MS; Wilson B
    Nanomedicine (Lond); 2010 Feb; 5(2):169-71. PubMed ID: 20148628
    [No Abstract]   [Full Text] [Related]  

  • 7. A Critical Review of the Use of Surfactant-Coated Nanoparticles in Nanomedicine and Food Nanotechnology.
    Miyazawa T; Itaya M; Burdeos GC; Nakagawa K; Miyazawa T
    Int J Nanomedicine; 2021; 16():3937-3999. PubMed ID: 34140768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticles for cancer therapy using magnetic forces.
    Tietze R; Lyer S; Dürr S; Alexiou C
    Nanomedicine (Lond); 2012 Mar; 7(3):447-57. PubMed ID: 22385201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomedicine approaches in acute lymphoblastic leukemia.
    Tatar AS; Nagy-Simon T; Tomuleasa C; Boca S; Astilean S
    J Control Release; 2016 Sep; 238():123-138. PubMed ID: 27460684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicine for targeted photothermal cancer therapy: where are we now?
    Chen F; Cai W
    Nanomedicine (Lond); 2015 Jan; 10(1):1-3. PubMed ID: 25597770
    [No Abstract]   [Full Text] [Related]  

  • 11. Microbial biofabrication for nanomedicine: biomaterials, nanoparticles and beyond.
    Vázquez E; Villaverde A
    Nanomedicine (Lond); 2013 Dec; 8(12):1895-8. PubMed ID: 24279484
    [No Abstract]   [Full Text] [Related]  

  • 12. Nanoparticles for thermal cancer therapy.
    Day ES; Morton JG; West JL
    J Biomech Eng; 2009 Jul; 131(7):074001. PubMed ID: 19640133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theranostic nanomedicine for cancer.
    Sumer B; Gao J
    Nanomedicine (Lond); 2008 Apr; 3(2):137-40. PubMed ID: 18373419
    [No Abstract]   [Full Text] [Related]  

  • 14. Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology.
    Ilinskaya AN; Dobrovolskaia MA
    Nanomedicine (Lond); 2013 May; 8(5):773-84. PubMed ID: 23656264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Above and Beyond Cancer Therapy: Translating Biomaterials into the Clinic.
    Conde J
    Trends Cancer; 2020 Sep; 6(9):730-732. PubMed ID: 32430152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theranostic nanomedicine.
    Chen X; Gambhir SS; Cheon J
    Acc Chem Res; 2011 Oct; 44(10):841. PubMed ID: 22004477
    [No Abstract]   [Full Text] [Related]  

  • 17. Conference scene: 2nd annual European conference for clinical nanomedicine.
    Löffler B
    Nanomedicine (Lond); 2009 Oct; 4(7):705-8. PubMed ID: 19839806
    [No Abstract]   [Full Text] [Related]  

  • 18. Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles.
    Lanza GM; Winter PM; Caruthers SD; Hughes MS; Cyrus T; Marsh JN; Neubauer AM; Partlow KC; Wickline SA
    Nanomedicine (Lond); 2006 Oct; 1(3):321-9. PubMed ID: 17716162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomedicine in the European Commission policy for nanotechnology.
    Gabellieri C; Frima H
    Nanomedicine; 2011 Oct; 7(5):519-20. PubMed ID: 21802394
    [No Abstract]   [Full Text] [Related]  

  • 20. Nanomedicine and society.
    Ferrari M; Philibert MA; Sanhai WR
    Clin Pharmacol Ther; 2009 May; 85(5):466-7. PubMed ID: 19381150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.